According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996.HK) announced the interim results for the six months ended June 30, 2026. The group's revenue was 513 million yuan, up 864.75% year on year; net profit was 216 million yuan, which turned a year-on-year loss into a profit; and profit per share was 0.34 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.